Ticker Details
Arvinas, Inc.
IPO Date:	September 24, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$612.34M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.05 | 3.14%
Avg Daily Range (30 D):	$0.20 | 2.32%
Avg Daily Range (90 D):	$0.22 | 2.46%

Institutional Daily Volume
Avg Daily Volume:	.61M
Avg Daily Volume (30 D):	.65M
Avg Daily Volume (90 D):	.64M

Trade Size
Avg Trade Size (Sh.):	72
Avg Trade Size (Sh.) (30 D):	69
Avg Trade Size (Sh.) (90 D):	61

Institutional Trades
Total Institutional Trades:	3,394
Avg Institutional Trade:	$2.14M
Avg Institutional Trade (30 D):	$1.02M
Avg Institutional Trade (90 D):	$1.18M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.48M
Avg Closing Trade (30 D):	$.91M
Avg Closing Trade (90 D):	$1.14M
Avg Closing Volume:	94.96K

News

Jun 4, 2026 @ 12:00 PM Arvinas Joins The Michael J. Fox Foundationâ€â„... Source: Na

May 20, 2026 @ 5:00 PM ESR1-Mutated Metastatic Breast Cancer Market Expec... Source: Delveinsight

May 12, 2026 @ 6:38 PM Rigel Pharmaceuticals Inks Breast Cancer Drug Deal... Source: Vandana Singh

May 5, 2026 @ 11:00 AM Arvinas to Report First Quarter 2026 Financial Res... Source: Na

May 4, 2026 @ 4:30 PM Pfizer, Arvinas Win FDA Nod For First-Of-Its-Kind ... Source: Vandana Singh

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS		$2.61	$-.9
Diluted EPS		$2.58	$-.9
Revenue		$249.7M	$15.6M
Gross Profit
Net Income / Loss		$169.4M	$-57.6M
Operating Income / Loss		$164.1M	$-63.8M
Cost of Revenue
Net Cash Flow		$7M	$-55.6M
PE Ratio